Search results
Results from the WOW.Com Content Network
Cancer profile models include the Breast Cancer Risk Assessment Tool (BCRAT), also known as the Gail Model. This tool assesses medical and reproductive history and history of cancer among first ...
A number of different tools exist, but the two most commonly used ones are the Breast Cancer Risk Assessment Tool (BCRAT, formerly called the “Gail Model”) and the International Breast Cancer ...
The result is a lifetime risk and a five-year risk based on factors that have been tied to a higher risk of breast cancer. For comparison, it also gives an average risk for U.S. women of the same ...
MammaPrint is a prognostic and predictive diagnostic test for early stage breast cancer patients that assess the risk that a tumor will metastasize to other parts of the body. [1] It gives a binary result, high-risk or low-risk classification , and helps physicians determine whether or not a patient will benefit from chemotherapy .
Staging breast cancer is the initial step to help physicians determine the most appropriate course of treatment. As of 2016, guidelines incorporated biologic factors, such as tumor grade, cellular proliferation rate, estrogen and progesterone receptor expression, human epidermal growth factor 2 (HER2) expression, and gene expression profiling into the staging system.
She uses a free interactive tool with all her patients to determine their risk level: the Tyrer-Cuzick Risk Assessment Calculator for breast cancer. The tool looks at personal, familial, and ...
Molecular classification of breast cancer from mRNA expression profiles. DNA microarrays have compared normal cells to breast cancer cells and found differences in the expression of hundreds of genes. Although the significance of many of those genetic differences is unknown, independent analyses by different research groups has found that ...
The Breast Cancer Risk Assessment Tool (BCRAT), also known as the Gail Model, is one of the most common and popular tests used to identify those women at risk for breast cancer, says Sherry Ross ...